Tag: medicine

Using AI machine learning, the Company discovers distinct biomarkers for detecting certain rare liver cancers that have stem cell characteristics and will include them as additional indications in its preclinical program

PRESS RELEASE

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color

CAMBRIDGE, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.^® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 72,000 restricted stock units of Arcutis’ common stock to nine newly hired employees. These awards were approved by the Compensation Committee of Arcutis’ Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of June 2, 2025, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).

SPRINGFIELD, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- The Dr. Louis Krenn Medical Scholarship announces a new opportunity for undergraduate and medical students across the United States to advance their journey toward a career in medicine. This prestigious one-time award, established by Dr. Louis Krenn, a distinguished Family Medicine physician, aims to support the next generation of healthcare professionals who demonstrate a commitment to service, innovation, and compassion. The scholarship, open to students nationwide, invites applicants to share their vision for the future of medicine through a thought-provoking essay.

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET

– Selected to Attend In-Person Event on June 5 led by FDA Commissioner Marty A. Makary, M.D., M.P.H. –